Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
2.530
+0.040 (1.61%)
At close: Sep 17, 2026, 4:00 PM EDT
2.550
+0.020 (0.79%)
Pre-market: Sep 18, 2026, 5:03 AM EDT
Virax Biolabs Group Market Cap
Virax Biolabs Group has a market cap or net worth of $2.02 million as of September 17, 2026. Its market cap has decreased by -26.30% in one year.
Market Cap
2.02M
Enterprise Value
-4.09M
1-Year Change
-26.30%
Ranking
Category
Stock Price
$2.53
ChartMarket Cap Chart
Since the IPO on July 21, 2022, Virax Biolabs Group's market cap has decreased from $207.01M to $2.02M, a decrease of -99.03%. That is a compound annual growth rate of -67.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 2.02M | -21.45% |
| Dec 31, 2025 | 2.57M | -73.72% |
| Dec 31, 2024 | 9.77M | 269.38% |
| Dec 29, 2023 | 2.64M | -71.76% |
| Dec 30, 2022 | 9.36M | -95.48% |
| Jul 21, 2022 | 207.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Matinas BioPharma Holdings | 2.32M |
| Curis | 2.28M |
| Oragenics | 2.23M |
| Tessera Defense and Homeland Security | 2.10M |
| Artelo Biosciences | 2.04M |
| Valion Bio | 1.94M |
| Propanc Biopharma | 1.87M |
| Silexion Therapeutics | 1.86M |